Eritoran Tetrasodium (B-1287; E-5564) is a novel, potent and selective Toll-like receptor 4 (TLR4) antagonist with the potential for the treatment of type 2 diabetes, attenuating liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) signaling.

纯度：≥98%

CAS：185954-98-7